Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 6/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 5/20 | 0.41 |
| ▸ | HTR3A | P46098 | 4/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.37 |
| ▸ | HSP90AA1 | P07900 | 3/20 | 0.37 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.37 |
| ▸ | ELANE | P08246 | 1/20 | 0.37 |
| ▸ | RORC | P51449 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4069708 | 0.90 | PDE4A (0.44) | PDE4AKCNH2HTR3APDE4BHDAC1 | |
| SCHEMBL4244200 | 0.87 | NR4A2 (0.39) | KCNH2HTR3AHSP90AA1HDAC1 | |
| Hydrochloric Acid SCHEMBL4240463 | 0.86 | HDAC1 (0.38) | KCNH2HTR3AHSP90AA1HDAC1 | |
| SCHEMBL4067237 | 0.84 | PDE4A (0.44) | PDE4AKCNH2HTR3ARORC | |
| SCHEMBL4059266 | 0.82 | HTR3A (0.55) | PDE4AKCNH2HTR3APKMRORC | |
| SCHEMBL4062258 | 0.82 | HTR3A (0.41) | PDE4AKCNH2HTR3AELANE | |
| SCHEMBL4061505 | 0.81 | HTR3A (0.47) | PDE4AKCNH2HTR3APKMELANE | |
| SCHEMBL4060222 | 0.81 | PDE4A (0.39) | PDE4AKCNH2HTR3APDE4BELANE | |
| SCHEMBL4236193 | 0.81 | KDR (0.39) | HTR3APDE4BHDAC1 | |
| SCHEMBL4058513 | 0.81 | KCNH2 (0.47) | PDE4AKCNH2HTR3APKMRORC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1641791-B1 | 3-(GUANIDINOCARBONYL)HETEROCYCLE DERIVATIVES, PREPARATION PROCESS AND INTERMEDIATES OF THIS PROCESS, THEIR USE AS MEDICAMENTS, AND PHARMACEUTICAL COMPOSITIONS INCLUDING THEM | SANOFI AVENTIS DEUTSCHLAND (DE) | 2009-07-29 | — | — | EP | claimed |